Protein citrullination: inhibition, identification and insertion
Philosophical Transactions of the Royal Society B: Biological Sciences · 20.11.2023 · 378 (1890)
DOI: 10.1098/rstb.2022.0240 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Philosophical Transactions of the Royal Society B: Biological Sciences, online erschienen am 02.10.2023. Verfasst von Leonard Barasa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Program in Chemical Biology, University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA 01605, USA. Hauptthemen laut MEDLINE: Citrullination, Arthritis, Rheumatoid. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Protein citrullination is a post-translational modification (PTM) that is catalysed by the protein arginine deiminase (PAD) family of enzymes. This PTM involves the transformation of an arginine residue into citrulline. Protein citrullination is associated with several physiological processes, including the epigenetic regulation of gene expression, neutrophil extracellular trap formation and DNA damage-induced apoptosis. Aberrant protein citrullination is relevant to several autoimmune and neurodegenerative diseases and certain forms of cancer. PAD inhibitors have shown remarkable efficacy in a range of diseases including rheumatoid arthritis (RA), lupus, atherosclerosis and ulcerative colitis. In RA, anti-citrullinated protein antibodies can be detected prior to disease onset and are thus a valuable diagnostic tool for RA. Notably, citrullinated proteins may serve more generally as biomarkers of specific disease states; however, the identification of citrullinated protein residues remains challenging owing to the small 1 Da mass change that occurs upon citrullination. Herein, we highlight the progress made so far in the development of pan-PAD and isozyme selective inhibitors as well as the identification of citrullinated proteins and the site-specific incorporation of citrulline into proteins. This article is part of the Theo Murphy meeting issue ‘The virtues and vices of protein citrullination’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Chemical Biology, University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA 01605, USA.
- Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA 01605, USA.
ORCID-Profile: Paul R Thompson
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Barasa, L., & Thompson, P. R. (2023). Protein citrullination: inhibition, identification and insertion. Philosophical Transactions of the Royal Society B: Biological Sciences, 378(1890). https://doi.org/10.1098/rstb.2022.0240
Vancouver
Barasa L, Thompson PR. Protein citrullination: inhibition, identification and insertion. Philosophical Transactions of the Royal Society B: Biological Sciences. 2023;378(1890). doi:10.1098/rstb.2022.0240
BibTeX
@article{Barasa2023,
author = {Barasa, Leonard and Thompson, Paul R},
title = {Protein citrullination: inhibition, identification and insertion},
journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
year = {2023},
volume = {378},
number = {1890},
doi = {10.1098/rstb.2022.0240}
}
EUVIMED